We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current HYPE3 market cap is 22.52B. The company's latest EPS is BRL and P/E is N/A.
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | |
| Total Revenue | 4.47B | 4.12B | 4.98B | 7.08B | 8.97B |
| Operating Income | 1.22B | 1.05B | 1.28B | 1.53B | 2.47B |
| Net Income | 1.13B | 1.16B | 1.3B | 1.33B | 1.7B |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | |
| Total Assets | 10.56B | 11.92B | 17.25B | 19.82B | 23.76B |
| Total Liabilities | 2.29B | 3.21B | 8.01B | 9.98B | 13.1B |
| Total Equity | 8.27B | 8.71B | 9.24B | 9.83B | 10.66B |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | |
| Operating | 1.06B | 823.88M | 1.18B | 1.4B | 2.04B |
| Investing | -170.53M | -306.53M | -1.9B | -4.41B | -1.74B |
| Financing | -771.23M | 82.21M | 3.21B | 557.06M | 278.96M |
| Market Cap | 22.52B |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 633.42M |
| Average Volume (1 week) | 3.33M |
| Average Volume (1 Month) | 3.27M |
| 52 Week Change | -16.7% |
| 52 Week High | 47.02 |
| 52 Week Low | 29.61 |
| Spread (Intraday) | 0.71 (1.98%) |
| Company Name | Hypera Pharma |
| Address |
rua nova cidade, 404 bairro, vila olimpia sao paulo, sao paulo 04547 070 |
| Website | https://www.hypermarcas.com.br |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
|
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions Support: 1-888-992-3836 | help@advfn.com |
| ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil |
| ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico |
| ADVFN France ADVFN US ADVFN Korea |
